TACE Guidance
Chairs: 
• Stephen Chan,  Associate Clinical Professor of the Department of Clinical Oncology in the Chinese University of Hong Kong.
• Riad Salem, Professor of Radiology, Medicine and Surgery Northwestern University, Chicago, USA

Speakers: 

• The ILCA consensus/guidance on TACE: Why, How and What?, Stephen Chan, Associate Clinical Professor of the Department of Clinical Oncology in the Chinese University of Hong Kong.

• The role of TACE in current era of HCC management OR Is selective TACE feasible and standard in most BCLC B patients?, Edward Kim, Director of Interventional Oncology and Assistant Professor of Radiology and Surgery in the Division of Vascular and Interventional Radiology at the Mount Sinai Medical Center. New York, USA.

• The use of systemic therapy in intermediate stage HCC: how to select,  Marina Baretti, Associate Professor of Oncology, John Hopkins Hospital, Baltimore, USA